Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

52.46 -0.27 (-0.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,908,848
Open 54.18
Bid (Size) 52.15 (1)
Ask (Size) 52.55 (5)
Prev. Close 52.73
Today's Range 51.52 - 54.90
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking Therapeutics Unusual Options Activity For June 12
Via Benzinga
3 Stocks Quietly Preparing for a 10X Surge: June Edition
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia. 
Via InvestorPlace

Performance

YTD
+186.98%
+186.98%
1 Month
-27.49%
-27.49%
3 Month
-21.82%
-21.82%
6 Month
+186.04%
+186.04%
1 Year
+121.02%
+121.02%

More News

Read More
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Via Investor's Business Daily
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Via The Motley Fool
This High-Flying Stock Just Announced More Good News: Time to Buy?
Via The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
Via InvestorPlace
Looking At Viking Therapeutics's Recent Unusual Options Activity
Via Benzinga
What's Going On With Viking Therapeutics Stock On Tuesday?
Via Benzinga
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Is Viking Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
Via Investor's Business Daily
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Via The Motley Fool
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Via The Motley Fool
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing
Via InvestorPlace
3 Underappreciated Stocks with Triple-Digit Upside: May 2024
Via InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.